TRPV1 antagonists (Georgetown University/Georgetown University Office of Technology Commercialization)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTRPV1 antagonists (Georgetown University/Georgetown University Office of Technology Commercialization)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVanilloid receptor antagonists
TargetsTransient receptor potential cation channel subfamily V member 1
Therapy Area/IndicationsPainInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGeorgetown University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGeorgetown University
Active IndicationsN/A
Inactive IndicationsPainInflammation

Other Information

ATC CodeN/A
Related LinksN/A